medroxyprogesterone acetate

FDA Drug Profile — Depo-Provera, medroxyprogesterone acetate, Provera, Depo-SubQ Provera, Medroxyprogesterone Acetate Injectable Suspension

medroxyprogesterone acetate is listed in the FDA National Drug Code directory with 25 NDC codes, marketed under brand names including Depo-Provera, medroxyprogesterone acetate, Provera. Available dosage forms: injection, suspension, tablet, powder.

Drug details

Generic Name
medroxyprogesterone acetate
Brand Names
Depo-Provera, medroxyprogesterone acetate, Provera, Depo-SubQ Provera, Medroxyprogesterone Acetate Injectable Suspension
Application Number
NDA020246
Sponsor
Pharmacia & Upjohn Company LLC
NDC Codes
25
Dosage Forms
INJECTION, SUSPENSION, TABLET, POWDER
Routes
INTRAMUSCULAR, ORAL, SUBCUTANEOUS
Active Ingredients
MEDROXYPROGESTERONE ACETATE

Indications and Usage

1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e. longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ] . Medroxyprogesterone acetate injectable suspension is a progestin indicated for use by females of reproductive potential to prevent pregnancy. (1) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. (1 , 5.1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.